BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $26,425,000 | -41.3% | 413,665 | -1.7% | 0.01% | -31.2% |
| Q4 2021 | $45,055,000 | -11.0% | 420,646 | -14.6% | 0.02% | -15.8% |
| Q3 2021 | $50,612,000 | +12.6% | 492,287 | -3.7% | 0.02% | +11.8% |
| Q2 2021 | $44,949,000 | -9.4% | 511,021 | +0.1% | 0.02% | -15.0% |
| Q1 2021 | $49,639,000 | -13.3% | 510,533 | -0.0% | 0.02% | -16.7% |
| Q4 2020 | $57,278,000 | +20.9% | 510,716 | -0.1% | 0.02% | +4.3% |
| Q3 2020 | $47,378,000 | +52.1% | 511,091 | +28.7% | 0.02% | +43.8% |
| Q2 2020 | $31,146,000 | +432.1% | 397,024 | +296.7% | 0.02% | +300.0% |
| Q1 2020 | $5,853,000 | -26.8% | 100,083 | -50.0% | 0.00% | 0.0% |
| Q1 2017 | $7,998,000 | +42.6% | 200,000 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $5,610,000 | – | 200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |